Product Description

Effective Dexmedetomidine & Medetomidine Reversal Agent for Dogs

Revertidine TM is indicated for the reversal of the clinical effects of the sedative and analgesic agents, dexmedetomidine hydrochloride and medetomidine hydrochloride, in dogs.

Dosage and Administration:
Revertidine TM is administered intramuscularly (IM) for reversal of sedation and analgesia regardless of the route used for dexmedetomidine or medetomidine. The atipamezole dose for the reversal of IV dexmedetomidine or medetomidine is 3750 mcg/m2 . The atipamezole dose for the reversal of IM dexmedetomidine or medetomidine is 5000 mcg/m2.